Navigation Links
WomenHeart Urges Women to Talk With Doctors About New Study Showing Statins Prevent Heart Attacks, Deaths
Date:11/10/2008

WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- WomenHeart today urged women to talk with their doctors about heart disease risk factors in light of new research demonstrating the impact of statin therapy (cholesterol-lowering drugs) on cardiovascular events in women. The study, called JUPITER, found that statin therapy prevents heart attacks, strokes and deaths in women - even those with normal cholesterol levels and no signs of heart disease.

"These new findings underscore the importance that women know their risk factors and ask their doctors what can be done to reduce them," said Lisa M. Tate, chief executive officer of WomenHeart: The National Coalition for Women with Heart Disease. "Heart disease is the number one killer of women, and about 500,000 die from it every year."

WomenHeart Champions are women living with heart disease who are willing to talk with media about their experience. Call 202-728-7199 or 301-213-6231

Presented at the American Heart Association's annual scientific meeting, the study found substantial reductions in deaths, strokes and heart attacks among patients taking statins. The study of nearly 18,000 patients - 38 percent of whom were women - may be the first study to demonstrate that statins prevent first heart attacks in women.

The study found that rosuvastatin (a potent statin) prevented heart attacks, strokes or death in people who had normal levels of LDL - or bad cholesterol, but high levels of a marker called C-reactive protein (CRP). This protein measures inflammation in the arteries, a condition that could lead to a heart attack. Both LDL cholesterol and CRP were significantly reduced with treatment.

While these findings could help save thousands of lives, Tate urges women to proceed with caution when considering making any changes to their heart health regimen and to be as informed as possible about their choices.

WomenHeart's Scientific Advisory Council wants women to know...

-- Statins are in a powerful class of drugs shown to reduce a person's

risk for heart disease and stroke.

-- Women known to be at risk may already be taking this medication as part

of their heart health regimen.

-- Like any drug, there are pros and cons to taking anything long term. It

is vitally important that women, who are not currently on a statin

regimen, talk with their doctor about what is right for them.

-- Discuss with your doctor whether you should have your C-reactive protein

(CRP) measured.

-- Undoubtedly, much information will be forthcoming from many sources

about the JUPITER study (http://www.crphealth.com/home/hcp/). It is

important to stay with credible sources of health and medical

information. Women should be cautious and consult their physicians

before making any changes to their heart health regimens.

WomenHeart is the only national, patient-centered organization dedicated to advancing women's heart health through advocacy, community education and patient support. A nonprofit advocacy organization, WomenHeart is a community of women heart patients and their families, health care providers, advocates and consumers committed to helping women live longer, healthier lives.

Visit WomenHeart's Web site at http://www.womenheart.org.


'/>"/>
SOURCE WomenHeart
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medicaid Health Plans of America Urges Congress to Pass Economic Recovery Package This Session Featuring Additional Funding for Medicaid
2. Michigan Business & Professional Association Urges Legislature to Act Quickly on Individual Health Care Reform
3. Malaria No More Congratulates President-elect Obama and the New Congress and Urges Them to Uphold Their Strong Commitment to Eliminating Malaria
4. GPhA Congratulates President-Elect Barack Obama and New Congress and Urges Action on Increasing Access to Generic -- and Biogeneric -- Medicines
5. Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen
6. RID Applauds Medicares New Payment Rule, Urges New York and All States to Follow
7. Child Life Council Urges Parents to Think Ahead to Ease Childs Hospital Visit
8. Testifying Before Congress, Trust for Americas Health Urges FDA Spending Cap Until Realistic Budget Request is Made
9. Red Cross Urges Safety in Wake of Hurricane Ike
10. American Red Cross Urges, Prepare for Ike
11. Consumer Reports Urges Chronic Headache Sufferers to Examine Their Use of Pain Relief Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... 2016 , ... Point Source Audio® (PSA) , an ... today that the US Patent Office has approved its patent submission that covers ... design creates a lightweight and modular audio headset that has been said to ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission ... Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction ... an accreditation distinction. ACHC provides a wide range of pharmacy accreditation services that ...
(Date:4/28/2016)... ... April 28, 2016 , ... Starting today, ... the mail from USA Medical Prescription Assistance Program. They are customized to reflect ... mailed package will include a ready-to-use, state-themed card and, in the near future, ...
(Date:4/28/2016)... ... April 28, 2016 , ... For the 10,000 Americans ... smarter about an important part of overall well-being: mental health. Now, a new book—Staying ... promote healthy aging and “cognitive vitality,” which can include everything from honing your memory ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... insurance co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy ... prescription medications from over 180 American pharmaceutical companies for $35 per month, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
Breaking Medicine Technology: